BNR Key Statistics, Chart & Performance
The current stock price of BNR is 34 USD. In the past month the price increased by 45.3%. In the past year, price increased by 424.69%.
BNR Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to BNR. When comparing the yearly performance of all stocks, BNR is one of the better performing stocks in the market, outperforming 99.45% of all stocks.
BNR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNR. Both the profitability and financial health of BNR have multiple concerns.
BNR Financial Highlights
Over the last trailing twelve months BNR reported a non-GAAP Earnings per Share(EPS) of -1.75. The EPS increased by 93.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.93% | ||
| ROE | -22.06% | ||
| Debt/Equity | 0 |
BNR Forecast & Estimates
For the next year, analysts expect an EPS growth of -277.41% and a revenue growth 48.35% for BNR
BNR Ownership
BNR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.39 | 394.886B | ||
| AMGN | AMGEN INC | 17.06 | 206.949B | ||
| GILD | GILEAD SCIENCES INC | 17.1 | 189.204B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.44 | 121.258B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.91 | 82.557B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.99 | 43.353B | ||
| INSM | INSMED INC | N/A | 31.961B | ||
| BIIB | BIOGEN INC | 13.22 | 29.513B | ||
| NTRA | NATERA INC | N/A | 28.022B | ||
| INCY | INCYTE CORP | 13.54 | 21.279B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BNR
Company Profile
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Company Info
BURNING ROCK BIOTECH LTD-ADR
No. 5 Xingdao Ring Road North, International Bio Island
Guangzhou GUANGDONG 510005 CN
CEO: Yusheng Han
Employees: 674
Phone: 8618501641666
BURNING ROCK BIOTECH LTD-ADR / BNR FAQ
Can you describe the business of BURNING ROCK BIOTECH LTD-ADR?
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Can you provide the latest stock price for BURNING ROCK BIOTECH LTD-ADR?
The current stock price of BNR is 34 USD. The price increased by 11.04% in the last trading session.
Does BNR stock pay dividends?
BNR does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNR stock?
BNR has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the employee count for BNR stock?
BURNING ROCK BIOTECH LTD-ADR (BNR) currently has 674 employees.
What is BURNING ROCK BIOTECH LTD-ADR worth?
BURNING ROCK BIOTECH LTD-ADR (BNR) has a market capitalization of 348.80M USD. This makes BNR a Small Cap stock.
What is the ownership structure of BURNING ROCK BIOTECH LTD-ADR (BNR)?
You can find the ownership structure of BURNING ROCK BIOTECH LTD-ADR (BNR) on the Ownership tab.